# OnCo record nsabp-foundation (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nsabp-foundation/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nsabp-foundation" ;
  schema:name "NSABP Foundation"@en ;
  schema:alternateName "National Surgical Adjuvant Breast and Bowel Project"@en, "NSABP"@en ;
  schema:description "The legacy US surgical adjuvant trials group that proved lumpectomy equals mastectomy, tamoxifen prevents breast cancer and trastuzumab cures more HER2-positive disease."@en ;
  schema:url <https://onco.cc/companies/nsabp-foundation/>, <https://www.nsabp.org> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.nsabp.org> ;
  onco:tag "cooperative-group" ;
  schema:addressCountry "US" ;
  onco:related <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/trastuzumab-emtansine/>, <https://onco.cc/drugs/oncotype-dx/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/surgery/>, <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/technologies/endocrine-therapy/>, <https://onco.cc/technologies/chemoprevention/> ;
  onco:companies <https://onco.cc/companies/nrg-oncology/>, <https://onco.cc/companies/gbg/> ;
  onco:institutions <https://onco.cc/institutions/nci/> ;
  onco:trials <https://onco.cc/trials/hera-b31-n9831/>, <https://onco.cc/trials/katherine/> ;
  onco:people <https://onco.cc/people/norman-wolmark/>, <https://onco.cc/people/priya-rastogi/> .